Radiation DosageAntineoplastic AgentsRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceRadiationDrug Screening Assays, AntitumorCell Line, TumorRadiation MonitoringRadiation ProtectionNeoplasmsDoxorubicinApoptosisDrug Resistance, NeoplasmRadiation OncologyCell SurvivalAntineoplastic Agents, PhytogenicCisplatinAntibiotics, AntineoplasticGamma RaysDrug Delivery SystemsCosmic RadiationRadiation Injuries, ExperimentalRadiometryTumor Cells, CulturedDrug CarriersRadiation PneumonitisDNA DamageNeoplasms, Radiation-InducedRadiotherapy DosageXenograft Model Antitumor AssaysMice, NudeRadiation-Sensitizing AgentsRadiotherapyBackground RadiationEllipticinesCell ProliferationUltraviolet RaysCombined Modality TherapyPaclitaxelEtoposideCamptothecinTime FactorsInhibitory Concentration 50Radiation EffectsDrug Resistance, MultipleP-GlycoproteinDrug SynergismMolecular StructureBreast NeoplasmsDose-Response Relationship, DrugCell CycleRadiation-Protective AgentsDrug DesignDose FractionationProdrugsEnzyme InhibitorsFluorouracilDNA RepairDNA Topoisomerases, Type IIDrug Evaluation, PreclinicalPlant ExtractsTreatment OutcomeLethal Dose 50Antineoplastic Combined Chemotherapy ProtocolsAcute Radiation SyndromeDaunorubicinTopoisomerase I InhibitorsNanoparticlesX-RaysGene Expression Regulation, NeoplasticRadiotherapy Planning, Computer-AssistedNanomedicineAntimetabolites, AntineoplasticNeoplasms, ExperimentalTumor Suppressor Protein p53Radioactive Hazard ReleaseNeoplasm TransplantationPlatinumColonic NeoplasmsRadiotherapy, Intensity-ModulatedDNACobalt RadioisotopesAdministration, OralRadiobiologyDrug Administration ScheduleOrganoplatinum CompoundsNanocapsulesDrug DiscoveryAntineoplastic Agents, AlkylatingCaspasesSignal TransductionCell DivisionModels, BiologicalBrain NeoplasmsBody BurdenCaspase 3Radiotherapy, ConformalProto-Oncogene Proteins c-bcl-2